Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine
Research output: Contribution to journal › Comment/debate › Research › peer-review
Standard
Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine. / Schmeling, Max; Manniche, Vibeke; Hansen, Peter Riis.
In: European Journal of Clinical Investigation, Vol. 53, No. 12, e14102, 2023.Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
Schmeling, M, Manniche, V & Hansen, PR 2023, 'Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine', European Journal of Clinical Investigation, vol. 53, no. 12, e14102. https://doi.org/10.1111/eci.14102
APA
Schmeling, M., Manniche, V., & Hansen, P. R. (2023). Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine. European Journal of Clinical Investigation, 53(12), [e14102]. https://doi.org/10.1111/eci.14102
Vancouver
Schmeling M, Manniche V, Hansen PR. Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine. European Journal of Clinical Investigation. 2023;53(12). e14102. https://doi.org/10.1111/eci.14102
Author
Bibtex
@article{77402b49d4884b56a4414ac0035b1a31,
title = "Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine",
author = "Max Schmeling and Vibeke Manniche and Hansen, {Peter Riis}",
year = "2023",
doi = "10.1111/eci.14102",
language = "English",
volume = "53",
journal = "European Journal of Clinical Investigation, Supplement",
issn = "0960-135X",
publisher = "Wiley-Blackwell",
number = "12",
}
RIS
TY - JOUR
T1 - Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine
AU - Schmeling, Max
AU - Manniche, Vibeke
AU - Hansen, Peter Riis
PY - 2023
Y1 - 2023
U2 - 10.1111/eci.14102
DO - 10.1111/eci.14102
M3 - Comment/debate
C2 - 37833825
AN - SCOPUS:85174013314
VL - 53
JO - European Journal of Clinical Investigation, Supplement
JF - European Journal of Clinical Investigation, Supplement
SN - 0960-135X
IS - 12
M1 - e14102
ER -
ID: 387461222